Form EFFECT Esperion Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 15, 2026 |
| Accession Number: | 0001104659-26-083009 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tony Robbins' No. 1 Bestseller Returns in Paperback Updated for the Next Wave of AI, Robotics, Energy and Space & Defense
- 2026 China International Woodball Open kicks off in Lianshui, Jiangsu
- More Than One-Third of Industrial Organizations See Cybersecurity Risk as a Top Obstacle to Growth, New Global Study Finds
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
